亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Design and Evaluation of Phosphonamidate-Linked Exatecan Constructs for Highly Loaded, Stable, and Efficacious Antibody–Drug Conjugates

喜树碱 连接器 体内 化学 有效载荷(计算) 组合化学 抗体-药物偶联物 结合 药理学 抗体 单克隆抗体 生物化学 计算机科学 生物 免疫学 数学 计算机网络 生物技术 网络数据包 操作系统 数学分析
作者
Saskia Schmitt,Paul Machui,Isabelle Mai,Sarah Herterich,Swetlana Wunder,Philipp Cyprys,Marcus Gerlach,Philipp Ochtrop,Christian P. R. Hackenberger,Dominik Schumacher,Jonas Helma,Annette M. Vogl,Marc‐André Kasper
出处
期刊:Molecular Cancer Therapeutics [American Association for Cancer Research]
卷期号:23 (2): 199-211 被引量:4
标识
DOI:10.1158/1535-7163.mct-23-0359
摘要

Abstract Topoisomerase I (TOP1) Inhibitors constitute an emerging payload class to engineer antibody–drug conjugates (ADC) as next-generation biopharmaceutical for cancer treatment. Existing ADCs are using camptothecin payloads with lower potency and suffer from limited stability in circulation. With this study, we introduce a novel camptothecin-based linker–payload platform based on the highly potent camptothecin derivative exatecan. First, we describe general challenges that arise from the hydrophobic combination of exatecan and established dipeptidyl p-aminobenzyl-carbamate (PAB) cleavage sites such as reduced antibody conjugation yields and ADC aggregation. After evaluating several linker–payload structures, we identified ethynyl-phosphonamidates in combination with a discrete PEG24 chain to compensate for the hydrophobic PAB–exatecan moiety. Furthermore, we demonstrate that the identified linker–payload structure enables the construction of highly loaded DAR8 ADCs with excellent solubility properties. Head-to-head comparison with Enhertu, an approved camptothecin-based ADC, revealed improved target-mediated killing of tumor cells, excellent bystander killing, drastically improved linker stability in vitro and in vivo and superior in vivo efficacy over four tested dose levels in a xenograft model. Moreover, we show that ADCs based on the novel exatecan linker–payload platform exhibit antibody-like pharmacokinetic properties, even when the ADCs are highly loaded with eight drug molecules per antibody. This ADC platform constitutes a new and general solution to deliver TOP1 inhibitors with highest efficiency to the site of the tumor, independent of the antibody and its target, and is thereby broadly applicable to various cancer indications.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
4秒前
洁净方盒发布了新的文献求助10
4秒前
kyokyoro完成签到,获得积分10
21秒前
21秒前
Kashing完成签到,获得积分10
26秒前
ZYP应助科研通管家采纳,获得10
29秒前
Shuo应助wuran采纳,获得10
41秒前
蜉蝣应助wuran采纳,获得10
41秒前
蜉蝣应助wuran采纳,获得10
41秒前
香蕉觅云应助wuran采纳,获得10
41秒前
蜉蝣应助wuran采纳,获得10
41秒前
机灵的衬衫完成签到 ,获得积分10
44秒前
46秒前
sunwei发布了新的文献求助10
51秒前
1分钟前
orixero应助积极的绫采纳,获得10
1分钟前
1分钟前
积极的绫发布了新的文献求助10
1分钟前
积极的绫完成签到,获得积分10
1分钟前
WuFen完成签到 ,获得积分10
2分钟前
2分钟前
科研通AI6应助冷静的魔镜采纳,获得10
2分钟前
完美世界应助科研通管家采纳,获得10
2分钟前
Kamalika完成签到,获得积分10
2分钟前
英俊的铭应助wuran采纳,获得10
2分钟前
2分钟前
1eegl发布了新的文献求助20
2分钟前
余十一完成签到 ,获得积分0
2分钟前
Lily发布了新的文献求助10
2分钟前
大个应助G1997采纳,获得10
2分钟前
2分钟前
2分钟前
3分钟前
小橘子吃傻子完成签到,获得积分0
3分钟前
3分钟前
LH完成签到,获得积分10
3分钟前
3分钟前
冷静的魔镜完成签到,获得积分20
3分钟前
3分钟前
eric_pty发布了新的文献求助10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各位详细阅读】【科研通的精品贴汇总】 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
F-35B V2.0 How to build Kitty Hawk's F-35B Version 2.0 Model 2000
줄기세포 생물학 1000
Determination of the boron concentration in diamond using optical spectroscopy 600
The Netter Collection of Medical Illustrations: Digestive System, Volume 9, Part III - Liver, Biliary Tract, and Pancreas (3rd Edition) 600
Founding Fathers The Shaping of America 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 催化作用 遗传学 冶金 电极 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 4527517
求助须知:如何正确求助?哪些是违规求助? 3967038
关于积分的说明 12293536
捐赠科研通 3632130
什么是DOI,文献DOI怎么找? 1999125
邀请新用户注册赠送积分活动 1035309
科研通“疑难数据库(出版商)”最低求助积分说明 924999